Oct 03, 2022 8:00 am EDT Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
Aug 02, 2022 4:05 pm EDT Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis
Jul 14, 2022 4:06 pm EDT Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)
May 16, 2022 8:00 am EDT Codexis Presents Pre-Clinical Data Highlighting Gene Therapy Programs at the ASGCT 25th Annual Meeting
Apr 21, 2022 8:00 am EDT Codexis and seqWell Announce Strategic Investment and Partnership Initiation
Apr 12, 2022 8:00 am EDT Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis
Jan 24, 2022 8:00 am EST Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria
Dec 15, 2021 8:00 am EST Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing
